| P50 | author | Christine Klein | Q21257320 |
| P2093 | author name string | Dimitri Krainc | |
| | Filip Simunovic | |
| | Hyun Jeong | |
| | Philip Seibler | |
| | John Graziotto | |
| P2860 | cites work | Feeder-free growth of undifferentiated human embryonic stem cells | Q34093315 |
| | Generation of human-induced pluripotent stem cells | Q34792230 |
| | Description of Parkinson's disease as a clinical syndrome. | Q35170978 |
| | Update on the genetics of Parkinson's disease | Q37050631 |
| | NANOG is a direct target of TGFbeta/activin-mediated SMAD signaling in human ESCs | Q37377843 |
| | Modelling pathogenesis and treatment of familial dysautonomia using patient-specific iPSCs. | Q37444336 |
| | Derivation of midbrain dopamine neurons from human embryonic stem cells | Q37493958 |
| | Peroxisome proliferator-activated receptor gamma co-activator 1alpha (PGC-1alpha) and sirtuin 1 (SIRT1) reside in mitochondria: possible direct function in mitochondrial biogenesis | Q38344199 |
| | Effect of endogenous mutant and wild-type PINK1 on Parkin in fibroblasts from Parkinson disease patients | Q39699315 |
| | Pink1 Parkinson mutations, the Cdc37/Hsp90 chaperones and Parkin all influence the maturation or subcellular distribution of Pink1. | Q40051916 |
| | Mitochondrial dysfunction, peroxidation damage and changes in glutathione metabolism in PARK6. | Q40201823 |
| | Co-amplification of nuclear pseudogenes and assessment of heteroplasmy of mitochondrial DNA mutations | Q41031930 |
| | Retrovirus silencing, variegation, extinction, and memory are controlled by a dynamic interplay of multiple epigenetic modifications | Q44963495 |
| | Transcriptional repression of PGC-1alpha by mutant huntingtin leads to mitochondrial dysfunction and neurodegeneration. | Q45302702 |
| | Thermoregulatory and metabolic defects in Huntington's disease transgenic mice implicate PGC-1alpha in Huntington's disease neurodegeneration | Q45302924 |
| | Production and purification of lentiviral vectors | Q46172190 |
| | Directed differentiation and transplantation of human embryonic stem cell-derived motoneurons. | Q51986995 |
| | Biological effects of the PINK1 c.1366C>T mutation: implications in Parkinson disease pathogenesis. | Q54562638 |
| | Clinical Spectrum of Homozygous and Heterozygous PINK1 Mutations in a Large German Family With Parkinson Disease | Q60332322 |
| | PINK1 is selectively stabilized on impaired mitochondria to activate Parkin | Q21145802 |
| | Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism | Q24309753 |
| | Parkin is recruited selectively to impaired mitochondria and promotes their autophagy | Q24317471 |
| | PINK1 is necessary for long term survival and mitochondrial function in human dopaminergic neurons | Q24322788 |
| | Hereditary early-onset Parkinson's disease caused by mutations in PINK1 | Q24337084 |
| | PGC-1 coactivators: inducible regulators of energy metabolism in health and disease | Q24541524 |
| | PGC-1α, a potential therapeutic target for early intervention in Parkinson's disease | Q24597726 |
| | CD15, CD24, and CD29 define a surface biomarker code for neural lineage differentiation of stem cells | Q24600745 |
| | PGC-1alpha expression decreases in the Alzheimer disease brain as a function of dementia | Q24604133 |
| | Disease-specific induced pluripotent stem cells | Q24641981 |
| | Transducer of regulated CREB-binding proteins (TORCs) induce PGC-1alpha transcription and mitochondrial biogenesis in muscle cells | Q24676703 |
| | Induction of pluripotent stem cells from adult human fibroblasts by defined factors | Q27860967 |
| | Reprogramming of human somatic cells to pluripotency with defined factors | Q28262710 |
| | Parkinson's disease patient-derived induced pluripotent stem cells free of viral reprogramming factors | Q28749672 |
| | A guided tour into subcellular colocalization analysis in light microscopy | Q29547199 |
| | Induced pluripotent stem cells from a spinal muscular atrophy patient | Q29614340 |
| | Highly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling | Q29615601 |
| | Mitochondrial dysfunction in Drosophila PINK1 mutants is complemented by parkin | Q29615684 |
| | Induced pluripotent stem cells generated from patients with ALS can be differentiated into motor neurons | Q29616199 |
| | Induction of pluripotent stem cells from primary human fibroblasts with only Oct4 and Sox2 | Q29617098 |
| | Suppression of reactive oxygen species and neurodegeneration by the PGC-1 transcriptional coactivators | Q29617353 |
| | PINK1-dependent recruitment of Parkin to mitochondria in mitophagy | Q29620567 |
| | Dynamics of three-dimensional replication patterns during the S-phase, analysed by double labelling of DNA and confocal microscopy | Q31042736 |
| | Parkinson disease, 10 years after its genetic revolution: multiple clues to a complex disorder | Q33344464 |
| | Silencing of PINK1 expression affects mitochondrial DNA and oxidative phosphorylation in dopaminergic cells | Q33415997 |
| P4510 | describes a project that uses | ImageJ | Q1659584 |
| P433 | issue | 16 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | mitochondrion | Q39572 |
| | regulation of protein targeting to mitochondrion | Q21106655 |
| P304 | page(s) | 5970-6 | |
| P577 | publication date | 2011-04-20 | |
| P1433 | published in | Journal of Neuroscience | Q1709864 |
| P1476 | title | Mitochondrial Parkin recruitment is impaired in neurons derived from mutant PINK1 induced pluripotent stem cells | |
| P478 | volume | 31 | |